Sanofi-Aventis Canada Inc. v. Teva Canada Limited, 2014 FCA 69 (Ramipril*)
Justice Sharlow; Justice Dawson; Justice Mainville - 2014-03-14
Read full decision. Automatically generated summary:
These reasons concern an appeal brought by Sanofi-Aventis Canada Inc. and Sanofi-Aventis Deutschland GmbH (“Sanofi”) from a judgment of Snider J. of the Federal Court (“Trial Judge”) dated May 11, 2012 and issued for reasons whose neutral citation is 2012 FC 551 and publicly released on May 23, 2012 (the “Validity Judgment”) which dismissed Sanofis’s submissions with respect to the validity, applicability or operability of section 8 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 (“NOC Regulations”).
Decision relates to:
- A-192-12 - SANOFI-AVENTIS CANADA INC. ET AL v. TEVA CANADA LTD. which is an appeal from 2012 FC 552 in T-1161-07